NSPR - InspireMD Inc Stock Price, Fair Value and News

3.41USD+0.43 (+14.43%)Market Closed

Market Summary

USD3.41+0.43

Market Closed

14.43%

NSPR Stock Price

View Fullscreen

NSPR RSI Chart

NSPR Valuation

Market Cap

85.0M

Price/Earnings (Trailing)

-3.75

Price/Sales (Trailing)

13.13

EV/EBITDA

-2.6

Price/Free Cashflow

-4.95

NSPR Price/Sales (Trailing)

NSPR Profitability

Operating Margin

62.48%

EBT Margin

-306.48%

Return on Equity

-64.67%

Return on Assets

-53.99%

Free Cashflow Yield

-20.19%

NSPR Fundamentals

NSPR Revenue

Revenue (TTM)

6.5M

Rev. Growth (Yr)

21.95%

Rev. Growth (Qtr)

-14.2%

NSPR Earnings

Earnings (TTM)

-22.7M

Earnings Growth (Yr)

-65.23%

Earnings Growth (Qtr)

-30.1%

Breaking Down NSPR Revenue

Last 7 days

44.5%

Last 30 days

37.0%

Last 90 days

70.5%

Trailing 12 Months

6.2%

How does NSPR drawdown profile look like?

NSPR Financial Health

Current Ratio

7.9

Debt/Equity

0.03

Debt/Cashflow

-15.11

NSPR Investor Care

Shares Dilution (1Y)

198.33%

Diluted EPS (TTM)

-0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	6.5M	0	0	0
2023	5.2M	5.3M	5.5M	6.2M
2022	4.7M	5.2M	5.5M	5.2M
2021	2.5M	3.2M	3.3M	4.5M
2020	4.3M	3.3M	3.3M	2.5M
2019	3.0M	3.4M	3.5M	3.7M
2018	3.2M	3.6M	3.6M	3.6M
2017	1.9M	2.0M	2.2M	2.8M
2016	2.4M	2.3M	2.1M	1.9M
2015	1.8M	2.3M	2.7M	2.3M
2014	6.1M	4.8M	3.5M	2.8M
2013	4.3M	4.9M	5.9M	6.1M
2012	5.5M	5.3M	3.9M	3.9M
2011	4.5M	4.7M	5.4M	6.0M
2010	0	3.9M	4.4M	4.9M
2009	0	0	0	3.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About InspireMD Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

CEO	Mr. Marvin L. Slosman
WEBSITE	inspiremd.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	55

InspireMD Inc Frequently Asked Questions

What is the ticker symbol for InspireMD Inc? What does NSPR stand for in stocks?

NSPR is the stock ticker symbol of InspireMD Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of InspireMD Inc (NSPR)?

As of Fri Jul 26 2024, market cap of InspireMD Inc is 85.01 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NSPR stock?

You can check NSPR's fair value in chart for subscribers.

Is InspireMD Inc a good stock to buy?

The fair value guage provides a quick view whether NSPR is over valued or under valued. Whether InspireMD Inc is cheap or expensive depends on the assumptions which impact InspireMD Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NSPR.

What is InspireMD Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, NSPR's PE ratio (Price to Earnings) is -3.75 and Price to Sales (PS) ratio is 13.13. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NSPR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on InspireMD Inc's stock?

In the past 10 years, InspireMD Inc has provided -0.821 (multiply by 100 for percentage) rate of return.